Ana Paula Santana de Vasconcellos

Hospital Israelita Albert Einstein

Papers

1

Total Citations

4

H-Index

1

About

Ana Paula Santana de Vasconcellos is a dedicated clinical researcher whose work centers on improving quality of life assessment for prostate cancer patients. Her primary research areas include psychometric validation of patient-reported outcome measures and the evaluation of functional outcomes following prostate cancer treatment. Her most notable contribution is the validation of the Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP), a streamlined tool designed to facilitate routine clinical assessment of urinary, bowel, sexual, and hormonal function. This work, published in 2020, involved rigorous psychometric testing and prospective application to capture early functional outcomes at a single institution, ensuring the instrument's reliability and clinical utility for Portuguese-speaking patients. By bridging a critical gap in culturally adapted assessment tools, her research directly enhances patient-centered care and enables more accurate tracking of treatment side effects. With 4 citations, this foundational study has already informed subsequent work in urological oncology. Vasconcellos’s commitment to methodological rigor and practical clinical application makes her a valuable contributor to the global effort to improve survivorship care for men with prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution
4 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Hospital Israelita Albert Einstein

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago